Efficacy and Safety of talazoparib (TALA) or Physician's choice of Therapy (PCT) in United States Patients (pts) with HER2- germline BRCA1/2-mutated (gBRCAm) Locally Advanced/metastatic Breast Cancer (LA/MBC) in the EMBRACA Study

Reshma Mahtani

Efficacy and Safety of talazoparib (TALA) or Physician's choice of Therapy (PCT) in United States Patients (pts) with HER2- germline BRCA1/2-mutated (gBRCAm) Locally Advanced/metastatic Breast Cancer (LA/MBC) in the EMBRACA Study

Reshma Mahtani

Miami Cancer Institute

Research output: Contribution to conference › Presentation

Abstract

S. Diab; H.S. Rugo; L.A. Mina; S. Puhalla; N.L. Henry; N. Denduluri; D, Yardley; Y. Wang; L. Shahied Arruda; I.C. Tudor; E. Gauthier; A. Czibere; J.K. Litton; S. Hurvitz

Original language	American English
State	Published - 2019
Event	Academy of Oncology Nurse & Patient Navigators 10th Annual Conference - Duration: Jan 1 2019 → …

Conference

Conference	Academy of Oncology Nurse & Patient Navigators 10th Annual Conference
Period	1/1/19 → …

Disciplines

Medicine and Health Sciences

Cite this

Efficacy and Safety of talazoparib (TALA) or Physician's choice of Therapy (PCT) in United States Patients (pts) with HER2- germline BRCA1/2-mutated (gBRCAm) Locally Advanced/metastatic Breast Cancer (LA/MBC) in the EMBRACA Study. / Mahtani, Reshma.
2019. Academy of Oncology Nurse & Patient Navigators 10th Annual Conference.

Research output: Contribution to conference › Presentation

@conference{a83a025144f04a088274216226604481,

title = "Efficacy and Safety of talazoparib (TALA) or Physician's choice of Therapy (PCT) in United States Patients (pts) with HER2- germline BRCA1/2-mutated (gBRCAm) Locally Advanced/metastatic Breast Cancer (LA/MBC) in the EMBRACA Study",

abstract = " S. Diab; H.S. Rugo; L.A. Mina; S. Puhalla; N.L. Henry; N. Denduluri; D, Yardley; Y. Wang; L. Shahied Arruda; I.C. Tudor; E. Gauthier; A. Czibere; J.K. Litton; S. Hurvitz ",

author = "Reshma Mahtani",

year = "2019",

language = "American English",

note = "Academy of Oncology Nurse \& Patient Navigators 10th Annual Conference ; Conference date: 01-01-2019",

}

TY - CONF

T1 - Efficacy and Safety of talazoparib (TALA) or Physician's choice of Therapy (PCT) in United States Patients (pts) with HER2- germline BRCA1/2-mutated (gBRCAm) Locally Advanced/metastatic Breast Cancer (LA/MBC) in the EMBRACA Study

AU - Mahtani, Reshma

PY - 2019

Y1 - 2019

N2 - S. Diab; H.S. Rugo; L.A. Mina; S. Puhalla; N.L. Henry; N. Denduluri; D, Yardley; Y. Wang; L. Shahied Arruda; I.C. Tudor; E. Gauthier; A. Czibere; J.K. Litton; S. Hurvitz

AB - S. Diab; H.S. Rugo; L.A. Mina; S. Puhalla; N.L. Henry; N. Denduluri; D, Yardley; Y. Wang; L. Shahied Arruda; I.C. Tudor; E. Gauthier; A. Czibere; J.K. Litton; S. Hurvitz

M3 - Presentation

T2 - Academy of Oncology Nurse & Patient Navigators 10th Annual Conference

Y2 - 1 January 2019

ER -